Amkor Technology looks expensive against its earnings, trading at 24x trailing and 19x next year's versus the roughly 18x chip-equipment makers usually get. At 18x mid-cycle EPS of $1.87, give or take 12%, fair value is $29.54-$37.60, putting the $53.86 price 43% above the top of that range. The view uses reported earnings and estimates only, without fundamental work. x.com 

Semiconductors still look likely to lag on a risk-adjusted basis, even if Treasury intervention such as yield-curve control changes the broader picture. They should have been rallying hard this week and are not acting right for bulls, suggesting something is brewing, probably a capex disappointment. Hyperscalers may be closer to another leg up. x.com  x.com  x.com 

Amkor's expansion in advanced packaging supports a bullish growth outlook as that work becomes more important. Packaging accounts for 88% of sales and computing revenue rose 25%; capacity spending explains negative free cash flow. Q3 EPS was $0.76, implying roughly 12x annualized earnings, while Q4 EPS guidance is $0.65-$0.75. The compute opportunity is only starting, despite the decline in mobile. x.com  x.com  x.com  x.com 

The sharp rebound in semiconductor and memory stocks does not confirm a durable bottom; many may stall below prior highs and form lower highs, making this a reflexive bounce within a broader correction. Unlike IREN and CoreWeave, semis and memory have not reached compelling valuations, and the backdrop is poor, with the 30-year yield higher and GDP estimates below expectations. The broader AI infrastructure theme remains extremely bullish. x.com 

Amkor's selloff on sandbagged guidance is wild given how the business is performing. The stock fell as much as 25% because revenue guidance was about $2.0B, even though Q2 revenue beat, EPS came in at $0.70 versus $0.48 expected, gross margin expanded to 16.8% and AI/HPC demand remains strong. Wall Street wanted perfection and punished anything less. x.com  x.com 

Amkor looks cheap at roughly 17x projected 2027 earnings of $2.83 a share, with its Arizona advanced-packaging capacity near TSM not expected to run near full utilization until 2028. The buildout has incurred substantial debt; the market may begin looking toward 2028 next year. The ramp remains prospective. x.com  x.com 

Customer prepayments of about $3.2B for Amkor's capacity exceed its roughly $2.5B planned capex this year, funding the buildout ahead of delivery. Buy, with a $48 target. x.com 

Amkor could be worth a small starter position because semiconductor packaging and test should keep growing, and Intel is using it as a partner to ramp EMIB-T packaging. The stock took a beating after earnings, so it may be worth waiting for a further drop in volatile markets. x.com 

Amkor Technology is clearly undervalued at a P/E of 20. Shares fell 25% after earnings even though Amkor announced an Nvidia partnership a few days earlier. x.com 

Amkor's operating leverage is kicking in, as rising utilization and outsized advanced-packaging demand let each new revenue dollar drop to profit at a far higher rate than a year ago. Its best quarter in years beat on both lines with records in AI end markets. Catalysts include a 10-year packaging deal with TSMC, a multi-year Nvidia partnership with prepayment for US capacity, a ramping HDFO data-center CPU program, and guidance for higher revenue and a meaningful gross margin jump. x.com